ICUI Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$176.62median target· current $168.51 (+4.8%)8 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio91.09Forward 20.66
EPS (TTM)$1.85-23.8% YoY
Profit margin2.1%HEALTHCARE
Market cap$4.21BMid cap
Valuation
- Forward P/E
- 20.66
- PEG ratio
- 0.10
- P/B
- 1.99
- P/S (TTM)
- 1.95
- EV/EBITDA
- 17.55
Profitability & growth
- ROE (TTM)
- 2.3%
- Operating margin
- 5.7%
- Revenue growth YoY
- -12.3%
- Dividend yield
- —
- Beta
- 0.76
Last earnings
May 7, 2026 · Estimate $1.75 · Reported $1.97
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About ICU Medical Inc
Company profileICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 951 CALLE AMANECER, SAN CLEMENTE, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$4.21B
Shares outstanding$25.0M
52W high$170.81
52W low$107.00
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent